Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment-Reference-Cited by-同舟云学术

Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment

Published:2023 Issue:50 Volume:13 Page:35240-35250
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Benny Feba¹,Oh Jong Min²,Kumar Sunil¹,Abdelgawad Mohamed A.³,Ghoneim Mohammed M.⁴,Abdel-Bakky Mohamed Sadek⁵,Kukerti Neelima⁶,Jose Jobin⁷^ORCID,Kim Hoon²^ORCID,Mathew Bijo¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682041, India

2. Department of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea

3. Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia

4. Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia

5. Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia

6. School of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand 248002, India

7. Department of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE University, Mangalore, Karnataka 575018, India

Abstract

Eighteen isatin-based benzyloxybenzaldehyde derivatives from three subseries, ISB, ISFB, and ISBB, were synthesized and their ability to inhibit monoamine oxidase (MAO) was evaluated.

Funder

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA07035B

Reference78 articles.

1. Epidemiology of Parkinson's disease

2. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease

3. Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

4. N.Eriksen , A. K.Stark and B.Pakkenberg , in Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra , Springer Vienna , Vienna , 2009 , pp. 203–213

5. Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease: A Recent Update and Challenge